Ocular Blood Flow Imaging for Glaucoma Assessment
NCT: NCT05726058 · RECRUITING
Brief Summary
The goal of this clinical trial is to investigate the use of an FDA-cleared retinal blood flow imaging instrument called the XyCAM RI and XyCAM FC (Vasoptic Medical, Inc., Columbia, MD) in glaucoma management. The main question it aims to answer are: * Can the investigators use blood flow to discriminate between eyes with early-stage glaucoma and variable-matched controls? * Can the investigators validate that the XyCAM FC simultaneously captures both stereo fundus photography and ocular blood flow monitoring? Participants will be * measured for their blood pressure, heart rate, height, and weight * dilated with tropicamide * imaged using the XyCAM RI, fundus photography, optical coherence tomography, and standard automated perimetry * imaged using the XyCAM RI while inhaling 100% oxygen through a mask
Frequently Asked Questions
What is Ocular Blood Flow Imaging for Glaucoma Assessment?
Ocular Blood Flow Imaging for Glaucoma Assessment is a clinical trial registered under NCT05726058. Current status: RECRUITING.
What is the status of NCT05726058?
The current status of NCT05726058 (Ocular Blood Flow Imaging for Glaucoma Assessment) is: RECRUITING.
When did Ocular Blood Flow Imaging for Glaucoma Assessment start?
Ocular Blood Flow Imaging for Glaucoma Assessment started on 2023-03-30.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.